Etoposide 20 mg/mL
Etoposide · INJECTION · Hikma Pharmaceuticals USA Inc.
Etoposide is a chemotherapy drug given by injection into a vein that works by inhibiting topoisomerase, an enzyme that helps cancer cells divide. It is used to treat certain types of cancer, including small cell lung cancer and testicular cancer.
Key Facts
- Brand Name
- Etoposide
- Generic Name
- Etoposide
- NDC Code (Product)
0143-9376- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA074290
- Drug Class
- Topoisomerase Inhibitor [EPC]
- Marketing Start
- 05/01/1996
Recall History
No Recall HistoryFrequently Asked Questions
What is Etoposide used for?
Etoposide is a chemotherapy drug given by injection into a vein that works by inhibiting topoisomerase, an enzyme that helps cancer cells divide. It is used to treat certain types of cancer, including small cell lung cancer and testicular cancer.
Is Etoposide a controlled substance?
Etoposide is not classified as a controlled substance by the DEA.
What is the generic name for Etoposide?
The generic name for Etoposide is Etoposide. There are 4 other brand versions of Etoposide.
What is the NDC code for Etoposide 20 mg/mL?
The NDC (National Drug Code) for Etoposide 20 mg/mL is 0143-9376, listed by Hikma Pharmaceuticals USA Inc..